Kawasaki, Japan

Akihiro Sugimura

This inventor holds 3 USPTO granted patents. Top assignee: Teikoku Hormone Mfg. Co., Ltd.. Active years: 1998-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akihiro Sugimura. Retrieved from https://idiyas.com/inventor/akihiro-sugimura-4h0edg9y

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 3

Forward Citations = 424(Granted Patents)


Company Filing History:


Years Active: 1998-2000

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Akihiro Sugimura: Innovator in Peptide Derivatives

Introduction

Akihiro Sugimura is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of peptide derivatives, holding a total of three patents. His work focuses on developing compounds with potential therapeutic applications, particularly in cancer treatment.

Latest Patents

One of Sugimura's latest patents involves a peptide derivative represented by a specific formula. This derivative exhibits antitumor activity that is stronger than that of dolastatin 10. It is recognized for its potential use as an anticancer or antitumor agent, showcasing the innovative nature of his research.

Career Highlights

Sugimura is associated with Teikoku Hormone Mfg. Co., Ltd., where he continues to advance his research in peptide derivatives. His work has garnered attention for its implications in medical science, particularly in oncology.

Collaborations

He has collaborated with notable coworkers, including Kyoichi Sakakibara and Masaaki Gondo. Their combined efforts contribute to the innovative research environment at their company.

Conclusion

Akihiro Sugimura's work in peptide derivatives highlights his role as a significant inventor in the field of medicinal chemistry. His contributions have the potential to impact cancer treatment positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…